Skip to main content
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1957 Dec;12(4):457–460. doi: 10.1111/j.1476-5381.1957.tb00165.x

The effects of mecamylamine in the cat as modified by the administration of carbon dioxide

J P Payne, G G Rowe
PMCID: PMC1510588  PMID: 13489174

Abstract

A series of cats, anaesthetized with chloralose, was given intravenously a sufficient quantity of mecamylamine to produce hypotension and a 50% neuromuscular block. Inhalation of carbon dioxide then produced a further depression of blood pressure and an increase in the neuromuscular blocking effect. It was shown that, following the administration of carbon dioxide, the plasma mecamylamine levels increased coincident with the increased pharmacological effects.

Full text

PDF
457

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAER J. E., BEYER K. H., PAULSON S. F., RUSSO H. F. Renal elimination of 3-methylaminoisocamphane hydrochloride (mecamylamine). Am J Physiol. 1956 Jul;186(1):180–186. doi: 10.1152/ajplegacy.1956.186.1.180. [DOI] [PubMed] [Google Scholar]
  2. BENNETT G., TYLER C., ZAIMIS E. Mecamylamine and its mode of action. Lancet. 1957 Aug 3;273(6988):218–222. doi: 10.1016/s0140-6736(57)91598-2. [DOI] [PubMed] [Google Scholar]
  3. PATON W. D. M., ZAIMIS E. The methonium. Pharmacol Rev. 1952 Sep;4(3):219–253. [PubMed] [Google Scholar]
  4. STONE C. A., TORCHIANA M. L., NAVARRO A., BEYER K. H. Ganglionic blocking properties of 3-methylaminoisocamphane hydrochloride (mecamylamine): a secondary amine. J Pharmacol Exp Ther. 1956 Jun;117(2):169–183. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES